Tim Roberts of PCI Pharma Services and Erem Latif of WestRock Healthcare examine how changes in healthcare legislation, alongside unprecedented merger and acquisition activity in the pharmaceutical industry, have increased the stakes in the clinical trials process – including increased outsourcing of clinical trials. Within a context of rising costs – from medication non-adherence and the need for ever wider global footprints – a patient-led approach is essential to help ensure compliance and, ultimately, clinical trial success.
https://www.jforcs.com/7/wp-content/uploads/2016/07/Prioritising-Patient-centricity.pdf